Table 4.
Trends of antimicrobial susceptibilities of Salmonella enterica clinical isolates (n = 49).
Antimicrobial agents | Salmonella enterica serotype Typhi (n = 22) | Salmonella enterica serotype Paratyphi (n = 27) | ||
---|---|---|---|---|
Resistance (%) | Resistance (%) | |||
Pediatric (n = 5) | Adults (n = 17) | Pediatric (n = 4) | Adults (n = 23) | |
Ampicillin | 0 (0.0) | 2 (11.7) | 1 (25.0) | 4 (17.3) |
Cotrimoxazole | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Ciprofloxacin | 4 (80.0) | 12 (70.5) | 3 (75.0) | 23 (100.0) |
Cefixime | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Ceftriaxone | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Chloramphenicol | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Azithromycin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |